Daliresp 250 ug/1

Daliresp 250 µg tablets contain roflumilast, a medication used to manage chronic obstructive pulmonary disease (COPD). This oral treatment helps reduce inflammation in the lungs, aiding breathing. Learn more about roflumilast uses and benefits.

Daliresp 250 µg tablets are primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Roflumilast, the active ingredient, works by reducing inflammation in the lungs, which can help improve breathing and reduce symptoms like wheezing and shortness of breath. This medication is not a rescue inhaler and should not be used for sudden breathing problems. Always consult a healthcare provider to determine if roflumilast is suitable for your condition.

Common effects of Daliresp 250 µg tablets may include headache, diarrhea, nausea, and weight loss. Some users might experience insomnia or dizziness. These effects vary among individuals and are not exhaustive. If you experience severe or persistent side effects, consult a healthcare professional.

Daliresp 250 µg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the tablets out of reach of children and pets. Do not share this medication with others, even if they have similar symptoms. Always follow the advice of a healthcare provider regarding the use of roflumilast.

Daliresp 250 µg tablets may interact with other medications, including those metabolized by the liver's CYP enzymes. Alcohol consumption should be avoided as it may exacerbate side effects. Inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.